Skip to content

Clinical trials

Terminated Metabolic Syndrome trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Syndrome Status: Terminated Country / region: Canada Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20081
20091
20101
20132
20142
20171
20182

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
Queen's University2
AHS Cancer Control Alberta1
Canadian Urologic Oncology Group1
Dr. B. Catharine. Craven1
Laval University1
Liminal BioSciences Ltd.1
Montreal Heart Institute1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Syndrome12
Obesity2
Prostatic Neoplasms2
Psychotic Disorders2
Schizophrenia2
Arteriosclerosis1
Bipolar Disorder1
Cardiovascular Diseases1
Carotid Artery Diseases1
Carotid Stenosis1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.